查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2036049

2026年全球醫藥供應鏈完整性市場報告

Pharmaceutical Supply Chain Integrity Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

近年來，醫藥供應鏈完整性市場規模顯著擴大。預計該市場規模將從2025年的40.2億美元成長到2026年的44.1億美元，複合年成長率達9.6%。過去幾年成長要素包括假藥案件增加、強制性監管合規、全球醫藥貿易擴張、條碼和序列化技術的應用以及對供應鏈透明度的需求。

預計未來幾年，醫藥供應鏈完整性市場規模將強勁成長，年複合成長率達9.9%，到2030年將達到64.2億美元。預測期內的成長預計將受到以下因素的推動：人工智慧監控系統的應用、基於雲端的追蹤溯源技術的實施、醫療和醫藥物流的擴張、物聯網設備的整合以及用於確保供應鏈完整性的預測分析。預測期內的關鍵趨勢包括：即時追蹤溯源解決方案、強化低溫運輸監控、自動化序列化流程、與ERP和SCM系統的整合以及供應鏈中的預測性風險管理。

數位轉型的加速預計將推動醫藥供應鏈完整性市場的成長。數位轉型是指將數位技術融入企業營運的各個層面，旨在提高營運效率、提升客戶體驗並推動創新。隨著企業努力提高效率、快速回應市場變化並保持競爭力，數位轉型的應用日益普及。在醫藥供應鏈中，數位轉型透過實現即時追蹤、基於區塊鏈的認證和高級分析來增強供應鏈完整性，從而防止假藥氾濫、確保合規性並維護產品品質。例如，根據英國政府機構中央數位與數據辦公室 (CDDO) 2023 年 11 月發布的報告，政府對數位轉型的重視使得政府數位數據相關職位數量在六個月內成長了 9%，專業人員總數達到 28,337 人。因此，數位轉型的擴展正在推動醫藥供應鏈完整性市場的成長。

在醫藥供應鏈完整性市場中，領先企業正致力於開發先進的解決方案，例如溫控倉庫，以確保藥品安全、維持產品療效並符合整個供應鏈的監管標準。溫控倉庫是一種旨在維持特定溫度範圍的儲存設施，以在整個供應鏈中保持對溫度敏感的藥品的品質、安全性和療效。例如，2025年8月，總部位於印度的低溫運輸物流公司Celsius 物流 Solutions Private Limited推出了其專注於溫控的醫藥低溫運輸部門Celsius+，初始投資為600萬美元（5億盧比）。該部門強調遵守GDP（藥品良好分銷規範）標準，透過遠端資訊處理和CCTV進行即時監控，利用人工智慧進行路線最佳化，並配備一支由100輛冷藏車組成的車隊，旨在最大限度地減少廢棄物，並確保從生產商到最終用戶的供應鏈完整性。

目錄

第1章：執行摘要

第2章 市場特徵

  • 市場定義和範圍
  • 市場區隔
  • 主要產品和服務概述
  • 全球醫藥供應鏈完整性市場：吸引力評分及分析
  • 成長潛力分析、競爭評估、策略適宜性評估、風險狀況評估

第3章 市場供應鏈分析

  • 供應鏈與生態系概述
  • 清單：主要原料、資源和供應商
  • 主要經銷商和通路合作夥伴名單
  • 主要最終用戶列表

第4章：全球市場趨勢與策略

  • 關鍵科技與未來趨勢
    • 數位化、雲端運算、巨量資料、網路安全
    • 工業4.0和智慧製造
    • 生物技術、基因組學和精準醫療
    • 擴展客製化資料擷取解決方案，以滿足小眾資料需求。
    • 金融科技、區塊鏈、監管科技與數位金融
  • 主要趨勢
    • 即時追蹤與追蹤解決方案
    • 增強低溫運輸監控能力
    • 自動化序列化流程
    • 與ERP和SCM系統的整合
    • 供應鏈預測性風險管理

第5章 終端用戶產業市場分析

  • 製藥公司
  • 醫療服務提供方
  • 物流運營商
  • 醫院
  • 藥局

第6章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅的影響、關稅戰和貿易保護主義對供應鏈的影響，以及 COVID-19 疫情對市場的影響。

第7章：全球策略分析架構、目前市場規模、市場對比及成長率分析

  • 全球醫藥供應鏈完整性市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素與限制因素）
  • 全球醫藥供應鏈完整性市場：規模、對比及成長率分析
  • 全球醫藥供應鏈完整性市場表現：規模與成長，2020-2025年
  • 全球醫藥供應鏈完整性市場預測：規模與成長，2025-2030年，2035年

第8章：全球市場總規模（TAM）

第9章 市場細分

  • 按組件
  • 軟體、硬體和服務
  • 透過技術
  • 序列化、追蹤與追溯系統、無線射頻辨識 (RFID) 系統
  • 部署模式
  • 雲端解決方案、本地部署解決方案
  • 透過使用
  • 製造商、經銷商、批發商、藥局、醫院和其他用戶
  • 最終用戶
  • 製藥公司、醫療保健提供者、物流公司和其他最終用戶
  • 細分：依類型：軟體
  • 追蹤溯源軟體、低溫運輸監控軟體、序列化軟體
  • 細分：依類型：硬體
  • 條碼掃描器、序列化印表機、追蹤器和物聯網設備
  • 細分：依類型：服務
  • 諮詢服務、維護和支援服務、整合和實施服務

第10章 區域與國別分析

第11章 亞太市場

第12章：中國市場

第13章：印度市場

第14章：日本市場

第15章：澳洲市場

第16章：印尼市場

第17章：韓國市場

第18章 台灣市場

第19章 東南亞市場

第20章 西歐市場

第21章英國市場

第22章：德國市場

第23章：法國市場

第24章：義大利市場

第25章：西班牙市場

第26章：東歐市場

第27章：俄羅斯市場

第28章 北美市場

第29章：美國市場

第30章：加拿大市場

第31章：南美市場

第32章：巴西市場

第33章 中東市場

第34章：非洲市場

第35章 市場監理與投資環境

第36章：競爭格局與公司概況

  • 醫藥供應鏈完整性市場：競爭格局及市場佔有率（2024年）
  • 醫藥供應鏈完整性市場：公司估值矩陣
  • 醫藥供應鏈完整性市場：公司簡介
    • Avery Dennison Corporation
    • Zebra Technologies Corporation
    • Testo SE & Co. KGaA
    • Marchesini Group SpA
    • Uhlmann Pac-Systeme GmbH & Co. KG

第37章 其他大型企業和創新企業

  • WIPOTEC GmbH, Schreiner Group GmbH & Co. KG, Antares Vision SpA, Controlant hf., TraceLink Inc., Optel Group Inc., Tive Inc., Roambee Corporation, Digimarc Corporation, SEA Vision Srl, ParkourSC Inc., Aeologic Technologies Private Limited, Kezzler AS, ACVISS Technologies Private Limited, Ciphercode Technologies Private Limited

第38章：全球市場競爭基準分析與儀錶板

第39章：預計進入市場的新創企業

第40章 重大併購

第41章 具有高市場潛力的國家、細分市場與策略

  • 2030年醫藥供應鏈完整性市場：提供新機會的國家
  • 2030年醫藥供應鏈完整性市場：蘊藏新機會的細分領域
  • 2030年醫藥供應鏈完整性市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第42章附錄

簡介目錄
Product Code: PH4MPSCI02_G26Q2

Pharmaceutical supply chain integrity involves ensuring that medicines and healthcare products preserve their safety, authenticity, and quality throughout the supply chain-from raw material sourcing and production to distribution and delivery to end users. It aims to prevent counterfeit, tampered, diverted, or substandard products from reaching the market.

The primary components of pharmaceutical supply chain integrity include software, hardware, and services. Software refers to platforms that monitor, manage, and secure the pharmaceutical supply chain, ensuring product authenticity and compliance. These solutions incorporate technologies such as serialization, track-and-trace systems, and radio frequency identification systems, deployed via cloud-based and on-premises solutions. Applications include manufacturers, distributors, wholesalers, pharmacies, hospitals, and other settings, serving pharmaceutical companies, healthcare providers, logistics providers, and other end users.

Tariffs have influenced the pharmaceutical supply chain integrity market by raising costs of importing specialized hardware, software, and tracking devices. Segments such as hardware and software are most affected, particularly in regions like North America and Europe dependent on imported technology. While tariffs increase operational costs, they also encourage local manufacturing, foster innovation in cost-efficient solutions, and strengthen domestic capabilities in supply chain management.

The pharmaceutical supply chain integrity market research report is one of a series of new reports from The Business Research Company that provides pharmaceutical supply chain integrity market statistics, including pharmaceutical supply chain integrity industry global market size, regional shares, competitors with a pharmaceutical supply chain integrity market share, detailed pharmaceutical supply chain integrity market segments, market trends and opportunities, and any further data you may need to thrive in the pharmaceutical supply chain integrity industry. This pharmaceutical supply chain integrity market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The pharmaceutical supply chain integrity market size has grown strongly in recent years. It will grow from $4.02 billion in 2025 to $4.41 billion in 2026 at a compound annual growth rate (CAGR) of 9.6%. The growth in the historic period can be attributed to rising counterfeit drug incidents, regulatory compliance mandates, growth of global pharmaceutical trade, adoption of barcode and serialization technology, demand for supply chain transparency.

The pharmaceutical supply chain integrity market size is expected to see strong growth in the next few years. It will grow to $6.42 billion in 2030 at a compound annual growth rate (CAGR) of 9.9%. The growth in the forecast period can be attributed to adoption of ai-powered monitoring systems, cloud-based track and trace implementation, expansion of healthcare and pharmaceutical logistics, integration of iot-enabled devices, predictive analytics for supply chain integrity. Major trends in the forecast period include real-time track and trace solutions, cold chain monitoring enhancement, automated serialization processes, integration with erp and scm systems, predictive risk management for supply chain.

The accelerating digital transformation is expected to support the growth of the pharmaceutical supply chain integrity market going forward. Digital transformation involves integrating digital technologies into all aspects of a business to enhance operations, improve customer experiences, and drive innovation. Adoption of digital transformation is rising as businesses seek to increase efficiency, respond swiftly to market changes, and remain competitive. In pharmaceutical supply chains, digital transformation enhances integrity by enabling real-time tracking, blockchain-based authentication, and advanced analytics to prevent counterfeit drugs, ensure regulatory compliance, and maintain product quality. For example, in November 2023, according to a report from the Central Digital and Data Office, a UK-based government entity, the government's focus on digital transformation resulted in a 9% growth in the Government Digital and Data profession over six months, bringing the total number of professionals to 28,337. Therefore, the expanding digital transformation is driving growth in the pharmaceutical supply chain integrity market.

Key companies operating in the pharmaceutical supply chain integrity market are focusing on developing advanced solutions such as temperature-controlled warehousing to ensure drug safety, maintain product efficacy, and comply with regulatory standards throughout the supply chain. Temperature-controlled warehousing refers to storage facilities designed to maintain specific temperature ranges to preserve the quality, safety, and efficacy of temperature-sensitive pharmaceutical products throughout the supply chain. For example, in August 2025, Celcius Logistics Solutions Private Limited, an India-based cold chain logistics company, launched Celcius+, a temperature-controlled dedicated pharma cold chain division, with an initial $0.006 billion (₹50 crore) investment. The initiative emphasizes GDP compliance, real-time monitoring via telematics and CCTV, AI-optimized routes, and a fleet of 100 reefer vehicles to minimize wastage and ensure supply chain integrity from manufacturer to end-user.

In February 2023, Overhaul Co., a US-based supply chain risk management and logistics technology company, acquired SensiGuard for an undisclosed amount. Through this acquisition, Overhaul seeks to enhance its life sciences supply chain integrity services by integrating SensiGuard's advanced monitoring and compliance solutions, supporting improved tracking, temperature-sensitive handling, and regulatory compliance. SensiGuard is a US-based technology company specializing in supply chain monitoring and security solutions for life sciences and pharmaceutical products.

Major companies operating in the pharmaceutical supply chain integrity market are Avery Dennison Corporation, Zebra Technologies Corporation, Testo SE & Co. KGaA, Marchesini Group S.p.A., Uhlmann Pac-Systeme GmbH & Co. KG, WIPOTEC GmbH, Schreiner Group GmbH & Co. KG, Antares Vision S.p.A., Controlant hf., TraceLink Inc., Optel Group Inc., Tive Inc., Roambee Corporation, Digimarc Corporation, SEA Vision S.r.l., ParkourSC Inc., Aeologic Technologies Private Limited, Kezzler AS, ACVISS Technologies Private Limited, Ciphercode Technologies Private Limited, AlpVision SA, Covectra Inc., Veratrak Ltd., PharmaSecure Inc., and Tracekey Solutions GmbH.

North America was the largest region in the pharmaceutical supply chain integrity market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the pharmaceutical supply chain integrity market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the pharmaceutical supply chain integrity market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The pharmaceutical supply chain integrity market consists of revenues earned by entities by providing services such as authentication services, compliance monitoring, and supply chain data analytics. The market value includes the value of related goods sold by the service provider or included within the service offering. The pharmaceutical supply chain integrity market also includes sales of barcode scanners, RFID readers, tamper-evident packaging systems, and serialization and labeling machines. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Pharmaceutical Supply Chain Integrity Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses pharmaceutical supply chain integrity market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for pharmaceutical supply chain integrity ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pharmaceutical supply chain integrity market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Component: Software; Hardware; Services
  • 2) By Technology: Serialization; Track And Trace Systems; Radio Frequency Identification Systems
  • 3) By Deployment Mode: Cloud-Based Solutions; On-Premises Solutions
  • 4) By Application: Manufacturers; Distributors; Wholesalers; Pharmacies; Hospitals; Other Applications
  • 5) By End-User: Pharmaceutical Companies; Healthcare Providers; Logistics Providers; Other End Users
  • Subsegments:
  • 1) By Software: Track and Trace Software; Cold Chain Monitoring Software; Serialization Software
  • 2) By Hardware: Barcode Scanners; Serialization Printers; Trackers And IoT Devices
  • 3) By Services: Consulting Services; Maintenance And Support Services; Integration And Implementation Services
  • Companies Mentioned: Avery Dennison Corporation; Zebra Technologies Corporation; Testo SE & Co. KGaA; Marchesini Group S.p.A.; Uhlmann Pac-Systeme GmbH & Co. KG; WIPOTEC GmbH; Schreiner Group GmbH & Co. KG; Antares Vision S.p.A.; Controlant hf.; TraceLink Inc.; Optel Group Inc.; Tive Inc.; Roambee Corporation; Digimarc Corporation; SEA Vision S.r.l.; ParkourSC Inc.; Aeologic Technologies Private Limited; Kezzler AS; ACVISS Technologies Private Limited; Ciphercode Technologies Private Limited; AlpVision SA; Covectra Inc.; Veratrak Ltd.; PharmaSecure Inc.; and Tracekey Solutions GmbH.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Pharmaceutical Supply Chain Integrity Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Pharmaceutical Supply Chain Integrity Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Pharmaceutical Supply Chain Integrity Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Pharmaceutical Supply Chain Integrity Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Biotechnology, Genomics & Precision Medicine
    • 4.1.4 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
    • 4.1.5 Fintech, Blockchain, Regtech & Digital Finance
  • 4.2. Major Trends
    • 4.2.1 Real-Time Track And Trace Solutions
    • 4.2.2 Cold Chain Monitoring Enhancement
    • 4.2.3 Automated Serialization Processes
    • 4.2.4 Integration With Erp And Scm Systems
    • 4.2.5 Predictive Risk Management For Supply Chain

5. Pharmaceutical Supply Chain Integrity Market Analysis Of End Use Industries

  • 5.1 Pharmaceutical Companies
  • 5.2 Healthcare Providers
  • 5.3 Logistics Providers
  • 5.4 Hospitals
  • 5.5 Pharmacies

6. Pharmaceutical Supply Chain Integrity Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Pharmaceutical Supply Chain Integrity Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Pharmaceutical Supply Chain Integrity PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Pharmaceutical Supply Chain Integrity Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Pharmaceutical Supply Chain Integrity Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Pharmaceutical Supply Chain Integrity Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Pharmaceutical Supply Chain Integrity Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Pharmaceutical Supply Chain Integrity Market Segmentation

  • 9.1. Global Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Software, Hardware, Services
  • 9.2. Global Pharmaceutical Supply Chain Integrity Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Serialization, Track And Trace Systems, Radio Frequency Identification Systems
  • 9.3. Global Pharmaceutical Supply Chain Integrity Market, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Cloud-Based Solutions, On-Premises Solutions
  • 9.4. Global Pharmaceutical Supply Chain Integrity Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Manufacturers, Distributors, Wholesalers, Pharmacies, Hospitals, Other Applications
  • 9.5. Global Pharmaceutical Supply Chain Integrity Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Pharmaceutical Companies, Healthcare Providers, Logistics Providers, Other End Users
  • 9.6. Global Pharmaceutical Supply Chain Integrity Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Track and Trace Software, Cold Chain Monitoring Software, Serialization Software
  • 9.7. Global Pharmaceutical Supply Chain Integrity Market, Sub-Segmentation Of Hardware, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Barcode Scanners, Serialization Printers, Trackers And IoT Devices
  • 9.8. Global Pharmaceutical Supply Chain Integrity Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Consulting Services, Maintenance And Support Services, Integration And Implementation Services

10. Pharmaceutical Supply Chain Integrity Market Regional And Country Analysis

  • 10.1. Global Pharmaceutical Supply Chain Integrity Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Pharmaceutical Supply Chain Integrity Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Pharmaceutical Supply Chain Integrity Market

  • 11.1. Asia-Pacific Pharmaceutical Supply Chain Integrity Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Pharmaceutical Supply Chain Integrity Market

  • 12.1. China Pharmaceutical Supply Chain Integrity Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Pharmaceutical Supply Chain Integrity Market

  • 13.1. India Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Pharmaceutical Supply Chain Integrity Market

  • 14.1. Japan Pharmaceutical Supply Chain Integrity Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Pharmaceutical Supply Chain Integrity Market

  • 15.1. Australia Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Pharmaceutical Supply Chain Integrity Market

  • 16.1. Indonesia Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Pharmaceutical Supply Chain Integrity Market

  • 17.1. South Korea Pharmaceutical Supply Chain Integrity Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Pharmaceutical Supply Chain Integrity Market

  • 18.1. Taiwan Pharmaceutical Supply Chain Integrity Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Pharmaceutical Supply Chain Integrity Market

  • 19.1. South East Asia Pharmaceutical Supply Chain Integrity Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Pharmaceutical Supply Chain Integrity Market

  • 20.1. Western Europe Pharmaceutical Supply Chain Integrity Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Pharmaceutical Supply Chain Integrity Market

  • 21.1. UK Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Pharmaceutical Supply Chain Integrity Market

  • 22.1. Germany Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Pharmaceutical Supply Chain Integrity Market

  • 23.1. France Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Pharmaceutical Supply Chain Integrity Market

  • 24.1. Italy Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Pharmaceutical Supply Chain Integrity Market

  • 25.1. Spain Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Pharmaceutical Supply Chain Integrity Market

  • 26.1. Eastern Europe Pharmaceutical Supply Chain Integrity Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Pharmaceutical Supply Chain Integrity Market

  • 27.1. Russia Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Pharmaceutical Supply Chain Integrity Market

  • 28.1. North America Pharmaceutical Supply Chain Integrity Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Pharmaceutical Supply Chain Integrity Market

  • 29.1. USA Pharmaceutical Supply Chain Integrity Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Pharmaceutical Supply Chain Integrity Market

  • 30.1. Canada Pharmaceutical Supply Chain Integrity Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Pharmaceutical Supply Chain Integrity Market

  • 31.1. South America Pharmaceutical Supply Chain Integrity Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Pharmaceutical Supply Chain Integrity Market

  • 32.1. Brazil Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Pharmaceutical Supply Chain Integrity Market

  • 33.1. Middle East Pharmaceutical Supply Chain Integrity Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Pharmaceutical Supply Chain Integrity Market

  • 34.1. Africa Pharmaceutical Supply Chain Integrity Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Pharmaceutical Supply Chain Integrity Market, Segmentation By Component, Segmentation By Technology, Segmentation By Deployment Mode, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Pharmaceutical Supply Chain Integrity Market Regulatory and Investment Landscape

36. Pharmaceutical Supply Chain Integrity Market Competitive Landscape And Company Profiles

  • 36.1. Pharmaceutical Supply Chain Integrity Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Pharmaceutical Supply Chain Integrity Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Pharmaceutical Supply Chain Integrity Market Company Profiles
    • 36.3.1. Avery Dennison Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Zebra Technologies Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Testo SE & Co. KGaA Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Marchesini Group S.p.A. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Uhlmann Pac-Systeme GmbH & Co. KG Overview, Products and Services, Strategy and Financial Analysis

37. Pharmaceutical Supply Chain Integrity Market Other Major And Innovative Companies

  • WIPOTEC GmbH, Schreiner Group GmbH & Co. KG, Antares Vision S.p.A., Controlant hf., TraceLink Inc., Optel Group Inc., Tive Inc., Roambee Corporation, Digimarc Corporation, SEA Vision S.r.l., ParkourSC Inc., Aeologic Technologies Private Limited, Kezzler AS, ACVISS Technologies Private Limited, Ciphercode Technologies Private Limited

38. Global Pharmaceutical Supply Chain Integrity Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Pharmaceutical Supply Chain Integrity Market

41. Pharmaceutical Supply Chain Integrity Market High Potential Countries, Segments and Strategies

  • 41.1 Pharmaceutical Supply Chain Integrity Market In 2030 - Countries Offering Most New Opportunities
  • 41.2 Pharmaceutical Supply Chain Integrity Market In 2030 - Segments Offering Most New Opportunities
  • 41.3 Pharmaceutical Supply Chain Integrity Market In 2030 - Growth Strategies
    • 41.3.1 Market Trend Based Strategies
    • 41.3.2 Competitor Strategies

42. Appendix

  • 42.1. Abbreviations
  • 42.2. Currencies
  • 42.3. Historic And Forecast Inflation Rates
  • 42.4. Research Inquiries
  • 42.5. The Business Research Company
  • 42.6. Copyright And Disclaimer